Expert Interviews

Dr. Samilia Obeng-GyasiBreast Cancer | April 1, 2024
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
View More
Stacy StephensAI | March 28, 2024
Stacy Stephens explains how autonomous security robots are boosting surveillance and communication in hospitals.
Arun KrishnaNon-Small Cell Lung Cancer | April 4, 2024
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
Shubham Pant, MD, MBBSPancreatic Cancer | March 15, 2024
Dr. Pant discusses the relationship between T cell response magnitude and tumor biomarker reduction.
Michael SpiglerVideos | March 15, 2024
Michael Spigler presents highlights of the American Kidney Fund's fifth annual Kidney Action Week.
Patrick DalyPNH | March 14, 2024
Dr. Griffin shares data from their real-world study on pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria.
Patrick DalyPolycythemia Vera | March 1, 2024
Dr. Grunwald of the Atrium Health Levine Cancer Institute, discusses caring for patients with PV on rare disease day.
Dr. Bob WalkerHypertension | February 29, 2024
Dr. Bob Walker discusses high blood pressure in the context of severe COVID-19 infection.
Gabriel Brooks, MDGI Cancer | February 27, 2024
Dr. Brooks explains the association between male sex and 5-FU exposure.
Zahra Pakbaz, MDSickle Cell Disease | February 27, 2024
Dr. Pakbaz describes some of the difficulties faced by patients with SCD as they switch from pediatric to adult programs.
Marisa Bittoni, PhDLung Cancer | February 22, 2024
Marisa Bittoni, PhD, talks about a large-scale study exploring factors that lead to lung cancer in patients younger than 50.
Cynthia Miller, MDLipid Management | February 21, 2024
Cynthia Miller, MD, MPH, FACP, discusses why early Lp(a) screening may help prevent cardiovascular disease.
Patrick DalySickle Cell Disease | February 13, 2024
Drs. Grant, Sutin, and Lin discuss their pilot study investigating cerebral hemodynamics in infants with sickle cell disease.
Pavlos Msaouel, MD, PhDOncology | February 12, 2024
What does the data and overall understanding of VEGF-TKIs tell us about which patients are optimal candidates for tivozanib?
John Strouse, MD, PhDSickle Cell Disease | March 19, 2024
Dr. Pakbaz and Dr. Strouse discuss their experiences practicing classical hematology and where the speciality is heading.
Patrick DalySickle Cell Disease | February 8, 2024
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Dr. Mark BleackleyRheumatology | February 2, 2024
Incannex announces the first dosing in a phase 2 study of a novel drug combination comprising HCQ and CBD to treat RA.
Ashley GainesBreast Cancer | January 18, 2024
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
Patrick DalyMyelofibrosis | February 16, 2024
Dr. Hobbs shared findings supporting the safety and feasibility of continuing ruxolitinib during and after HSCT for MF.
Christopher Lieu, MDASCO GI 2024 | January 23, 2024
Dr. Christopher Lieu gives an overview of some of the top presentations and data to look out for at ASCO GI 2024.
Dr. Richard LafayetteChronic Kidney Disease | February 5, 2024
Dr. Richard Lafayette discusses the FDA approval of TARPEYO, which reduces the loss of kidney function in IgA nephropathy.
Advertisement
Advertisement
Advertisement
Advertisement
Latest News

April 12, 2024